rosiglitazone has been researched along with acetaldehyde in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, CW; Cha, BS; Jung, TW; Kang, ES; Kim, SK; Lee, HC; Lee, JY; Shim, WS | 1 |
| Floreani, NA; Haorah, J; Knipe, B; Persidsky, Y | 1 |
2 other study(ies) available for rosiglitazone and acetaldehyde
| Article | Year |
|---|---|
Rosiglitazone protects human neuroblastoma SH-SY5Y cells against acetaldehyde-induced cytotoxicity.
Topics: Acetaldehyde; Apoptosis; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Combinations; Humans; Neuroblastoma; Neuroprotective Agents; Rosiglitazone; Thiazolidinediones | 2006 |
Stabilization of superoxide dismutase by acetyl-l-carnitine in human brain endothelium during alcohol exposure: novel protective approach.
Topics: Acetaldehyde; Acetylcarnitine; Anti-Inflammatory Agents; Blood-Brain Barrier; Brain; Catalase; Cells, Cultured; Endothelial Cells; Ethanol; Humans; Nitric Oxide; Oxidative Stress; Reactive Oxygen Species; Rosiglitazone; Superoxide Dismutase; Thiazolidinediones | 2011 |